Found: 93
Select item for more details and to access through your institution.
Individualizing piperacillin/tazobactam dosing in adult patients with cystic fibrosis: can tobramycin measurements help?
- Published in:
- 2019
- By:
- Publication type:
- journal article
Review of the In Vitro Microbiological Activity of Mecillinam Against Common Uropathogens in Uncomplicated Urinary Tract Infection: Focus on Resistant Pathogens.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 6, p. 1, doi. 10.1093/ofid/ofae296
- By:
- Publication type:
- Article
Healthcare Resource Utilization and Discharge Readiness in Adult Hospitalized Patients With Candidemia or Invasive Candidiasis Who Received an Echinocandin: An Analysis of United States Hospitals.
- Published in:
- Open Forum Infectious Diseases, 2024, v. 11, n. 1, p. 1, doi. 10.1093/ofid/ofad703
- By:
- Publication type:
- Article
Correction to: Decision Analysis: Omadacycline Relative to Moxifoxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difcile Infection.
- Published in:
- 2021
- By:
- Publication type:
- Correction Notice
Decision Analysis: Omadacycline Relative to Moxifloxacin Among Hospitalized Community-Acquired Bacterial Pneumonia Patients at Risk of Clostridioides difficile Infection.
- Published in:
- Clinical Drug Investigation, 2021, v. 41, n. 3, p. 269, doi. 10.1007/s40261-021-01005-w
- By:
- Publication type:
- Article
The Role of Delafloxacin in Patients with Community-Acquired Bacterial Pneumonia in the Outpatient Setting: A Budget Impact Model.
- Published in:
- Clinical Drug Investigation, 2020, v. 40, n. 10, p. 961, doi. 10.1007/s40261-020-00938-y
- By:
- Publication type:
- Article
Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection.
- Published in:
- Clinical Infectious Diseases, 2024, v. 78, n. 4, p. 833, doi. 10.1093/cid/ciad636
- By:
- Publication type:
- Article
Priorities and Progress in Gram-positive Bacterial Infection Research by the Antibacterial Resistance Leadership Group: A Narrative Review.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S295, doi. 10.1093/cid/ciad565
- By:
- Publication type:
- Article
Priorities and Progress in Gram-negative Bacterial Infection Research by the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2023, v. 77, p. S305, doi. 10.1093/cid/ciad547
- By:
- Publication type:
- Article
Vancomycin Area Under the Curve to Predict Timely Clinical Response in the Treatment of Methicillin-resistant Staphylococcus aureus Complicated Skin and Soft Tissue Infections.
- Published in:
- Clinical Infectious Diseases, 2021, v. 73, n. 11, p. e4560, doi. 10.1093/cid/ciaa1039
- By:
- Publication type:
- Article
Questions on Vancomycin Dosing.
- Published in:
- 2021
- By:
- Publication type:
- Letter to the Editor
Vancomycin Area Under the Curve–Guided Dosing and Monitoring for Adult and Pediatric Patients With Suspected or Documented Serious Methicillin-Resistant Staphylococcus aureus Infections: Putting the Safety of Our Patients First.
- Published in:
- Clinical Infectious Diseases, 2021, v. 72, n. 9, p. 1497, doi. 10.1093/cid/ciaa1744
- By:
- Publication type:
- Article
Therapeutic Monitoring of Vancomycin for Serious Methicillin-resistant Staphylococcus aureus Infections: A Revised Consensus Guideline and Review by the American Society of Health-system Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
- Published in:
- Clinical Infectious Diseases, 2020, v. 71, n. 6, p. 1361, doi. 10.1093/cid/ciaa303
- By:
- Publication type:
- Article
The Emperor's New Clothes: PRospective Observational Evaluation of the Association Between Initial VancomycIn Exposure and Failure Rates Among ADult HospitalizEd Patients With Methicillin-resistant Staphylococcus aureus Bloodstream Infections (PROVIDE).
- Published in:
- Clinical Infectious Diseases, 2020, v. 70, n. 8, p. 1536, doi. 10.1093/cid/ciz460
- By:
- Publication type:
- Article
The 30-Day Economic Burden of Newly Diagnosed Complicated Urinary Tract Infections in Medicare Fee-for-Service Patients Who Resided in the Community.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 5, p. 578, doi. 10.3390/antibiotics11050578
- By:
- Publication type:
- Article
Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 12, p. 905, doi. 10.3390/antibiotics9120905
- By:
- Publication type:
- Article
Hospital Admission Patterns in Adult Patients with Community-Acquired Pneumonia Who Received Ceftriaxone and a Macrolide by Disease Severity across United States Hospitals.
- Published in:
- Antibiotics (2079-6382), 2020, v. 9, n. 9, p. 577, doi. 10.3390/antibiotics9090577
- By:
- Publication type:
- Article
Response to the Letter to the Editor Regarding "Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies" [Response to Letter].
- Published in:
- International Journal of COPD, 2021, v. 16, p. 1227, doi. 10.2147/COPD.S315195
- By:
- Publication type:
- Article
Intraclass Difference in Pneumonia Risk with Fluticasone and Budesonide in COPD: A Systematic Review of Evidence from Direct-Comparison Studies.
- Published in:
- International Journal of COPD, 2020, v. 15, p. 2889, doi. 10.2147/COPD.S269637
- By:
- Publication type:
- Article
Hospital Readmissions and Mortality Among Intubated and Mechanically Ventilated Adult Subjects With Pneumonia Due to Gram-Negative Bacteria.
- Published in:
- Respiratory Care, 2021, v. 66, n. 5, p. 742, doi. 10.4187/respcare.07754
- By:
- Publication type:
- Article
Gram-Positive Bacterial Infections: Research Priorities, Accomplishments, and Future Directions of the Antibacterial Resistance Leadership Group.
- Published in:
- Clinical Infectious Diseases, 2017, v. 64, p. S24, doi. 10.1093/cid/ciw827
- By:
- Publication type:
- Article
Vancomycin Exposure in Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections: How Much Is Enough?
- Published in:
- Clinical Infectious Diseases, 2014, v. 59, n. 5, p. 666, doi. 10.1093/cid/ciu398
- By:
- Publication type:
- Article
Use of Pharmacokinetic/Pharmacodynamic Systems Analyses to Inform Dose Selection of Tedizolid Phosphate.
- Published in:
- Clinical Infectious Diseases, 2014, v. 58, n. suppl_1, p. S28, doi. 10.1093/cid/cit615
- By:
- Publication type:
- Article
Editorial Commentary: Saving Lives With Optimal Antimicrobial Chemotherapy.
- Published in:
- 2013
- By:
- Publication type:
- Editorial
Vancomycin: We Can't Get There from Here.
- Published in:
- Clinical Infectious Diseases, 2011, v. 52, n. 8, p. 969, doi. 10.1093/cid/cir078
- By:
- Publication type:
- Article
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients.
- Published in:
- Clinical Infectious Diseases, 2009, v. 49, n. 4, p. 507, doi. 10.1086/600884
- By:
- Publication type:
- Article
Clinical Risk Scores to Predict Nonsusceptibility to Trimethoprim-Sulfamethoxazole, Fluoroquinolone, Nitrofurantoin, and Third-Generation Cephalosporin Among Adult Outpatient Episodes of Complicated Urinary Tract Infection.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 8, p. 1, doi. 10.1093/ofid/ofad319
- By:
- Publication type:
- Article
Epidemiology of Complicated Urinary Tract Infections due to Enterobacterales Among Adult Patients Presenting in Emergency Departments Across the United States.
- Published in:
- 2022
- By:
- Publication type:
- Case Study
Retrospective Cohort Study of the 12-Month Epidemiology, Treatment Patterns, Outcomes, and Health Care Costs Among Adult Patients With Complicated Urinary Tract Infections.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 7, p. 1, doi. 10.1093/ofid/ofac307
- By:
- Publication type:
- Article
Associations Between Vancomycin Exposure and Acute Kidney Injury Within the Recommended Area Under the Curve Therapeutic Exposure Range Among Patients With Methicillin-Resistant Staphylococcus aureus Bloodstream Infections.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 2, p. 1, doi. 10.1093/ofid/ofab651
- By:
- Publication type:
- Article
US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated Urinary Tract Infections due to Enterobacterales.
- Published in:
- Open Forum Infectious Diseases, 2021, v. 8, n. 10, p. 1, doi. 10.1093/ofid/ofab380
- By:
- Publication type:
- Article
Using Therapeutic Drug Monitoring to Treat KPC-Producing Klebsiella pneumoniae Central Nervous System Infection With Ceftazidime/Avibactam.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 9, p. 1, doi. 10.1093/ofid/ofaa349
- By:
- Publication type:
- Article
An Evaluation of Treatment Patterns and Associated Outcomes Among Adult Hospitalized Patients With Lower-Risk Community-Acquired Complicated Intra-abdominal Infections: How Often Are Expert Guidelines Followed?
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 7, p. 1, doi. 10.1093/ofid/ofaa237
- By:
- Publication type:
- Article
Health-Related Quality of Life as Measured by the 12-Item Short-Form Survey Among Adults With Community-Acquired Bacterial Pneumonia who Received Either Lefamulin or Moxifloxacin in 2 Phase III Randomized, Double-Blind, Double-Dummy Clinical Trials.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 6, p. 1, doi. 10.1093/ofid/ofaa209
- By:
- Publication type:
- Article
Corrigendum to: Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection.
- Published in:
- Open Forum Infectious Diseases, 2020, v. 7, n. 1, p. N.PAG, doi. 10.1093/ofid/ofz536
- By:
- Publication type:
- Article
Comparisons of 30-Day Admission and 30-Day Total Healthcare Costs Between Patients Who Were Treated With Oritavancin or Vancomycin for a Skin Infection in the Outpatient Setting.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 12, p. N.PAG, doi. 10.1093/ofid/ofz475
- By:
- Publication type:
- Article
Longitudinal, Nationwide, Cohort Study to Assess Incidence, Outcomes, and Costs Associated With Complicated Urinary Tract Infection.
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 11, p. N.PAG, doi. 10.1093/ofid/ofz446
- By:
- Publication type:
- Article
Antimicrobial Resistance or Delayed Appropriate Therapy—Does One Influence Outcomes More Than the Other Among Patients With Serious Infections Due to Carbapenem-Resistant Versus Carbapenem-Susceptible Enterobacteriaceae?
- Published in:
- Open Forum Infectious Diseases, 2019, v. 6, n. 6, p. 1, doi. 10.1093/ofid/ofz194
- By:
- Publication type:
- Article
Ceftaroline Fosamil in the Treatment of Community-Acquired Bacterial Pneumonia and Acute Bacterial Skin and Skin Structure Infections.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Therapeutic monitoring of vancomycin for serious methicillin-resistant Staphylococcus aureus infections: A revised consensus guideline and review by the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, the Pediatric Infectious Diseases Society, and the Society of Infectious Diseases Pharmacists
- Published in:
- American Journal of Health-System Pharmacy, 2020, v. 77, n. 11, p. 835, doi. 10.1093/ajhp/zxaa036
- By:
- Publication type:
- Article
Development of a bedside tool to predict the probability of drug-resistant pathogens among hospitalized adult patients with gram-negative infections.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration.
- Published in:
- Pharmacotherapy, 2023, v. 43, n. 1, p. 24, doi. 10.1002/phar.2747
- By:
- Publication type:
- Article
Gut microbiome health and dysbiosis: A clinical primer.
- Published in:
- Pharmacotherapy, 2022, v. 42, n. 11, p. 849, doi. 10.1002/phar.2731
- By:
- Publication type:
- Article
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 11, p. 915, doi. 10.1002/phar.2625
- By:
- Publication type:
- Article
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 9, p. 762, doi. 10.1002/phar.2607
- By:
- Publication type:
- Article
Outcomes of adult patients in the intensive care unit with Pseudomonas aeruginosa pneumonia who received an active anti-pseudomonal β-lactam: Does "S" equal success in the presence of resistance to other anti-pseudomonal β-lactams?
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 8, p. 658, doi. 10.1002/phar.2600
- By:
- Publication type:
- Article
Comparative effectiveness of early‐targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans' affairs patients with infections due to Clostridioides difficile.
- Published in:
- Pharmacotherapy, 2021, v. 41, n. 2, p. 212, doi. 10.1002/phar.2503
- By:
- Publication type:
- Article
Vancomycin Area Under the Curve‐guided Dosing and Monitoring: "Is the Juice Worth the Squeeze"?
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 12, p. 1176, doi. 10.1002/phar.2482
- By:
- Publication type:
- Article
Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections.
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 9, p. 952, doi. 10.1002/phar.2449
- By:
- Publication type:
- Article
Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram‐negative Bloodstream Infections: "Every day matters".
- Published in:
- Pharmacotherapy, 2020, v. 40, n. 9, p. 889, doi. 10.1002/phar.2446
- By:
- Publication type:
- Article